Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, we are dedicated to achieving these goals in Washington, D.C. and across the country.

Featured Blogs

Voter insights: Four things to know

Tom Wilbur
Tom Wilbur
The 2024 elections are well underway, and we’re continuing to track insights voters are sharing about their priorities and the issues that matter most to them.

PBMs using 340B program to drive profits at patients’ expense

Nicole Longo
Congress should put an end to the exploitation of this important safety-net program and put it back on track for the patients it was meant to assist.

The impact of innovative medicines: A caregiver's perspective

Headshot of Liz Mahar
Liz Mahar
As someone who has had family members impacted by serious illness, I know that biopharmaceutical progress in recent decades has improved patient outcomes immensely, helping people enjoy healthier, more fulfilling lives.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.